Jim Simons Forte Biosciences, Inc. Transaction History

Renaissance Technologies LLC

$63.6 Billion
Q1 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Forte Biosciences, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 132,100 shares of FBRX stock, worth $77,939. This represents 0.0% of its overall portfolio holdings.

Number of Shares

132,100

Previous 129,800 1.77%

Holding current value

$77,939

Previous $107,000 14.02%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$0.48 - $0.85 $1,104 - $1,955	2,300 Added 1.77%	132,100 $92,000
Q4 2023 Feb 13, 2024	BUY	$0.38 - $0.82 $1,102 - $2,378	2,900 Added 2.29%	129,800 $107,000
Q3 2023 Nov 14, 2023	SELL	$0.65 - $1.04 $50,635 - $81,016	-77,900 Reduced 38.04%	126,900 $84,000
Q2 2023 Aug 11, 2023	SELL	$0.98 - $1.11 $8,526 - $9,657	-8,700 Reduced 4.07%	204,800 $213,000
Q1 2023 May 12, 2023	SELL	$0.98 - $1.06 $62,720 - $67,840	-64,000 Reduced 23.06%	213,500 $216,000

Q4 2022 Feb 13, 2023	SELL	$0.96 - $1.04 $159,963 - $173,294	-166,629 Reduced 37.52%	277,500 $278,000
Q3 2022 Nov 14, 2022	BUY	$1.06 - $1.53 $241,074 - $347,966	227,429 Added 104.95%	444,129 $475,000
Q2 2022 Aug 12, 2022	BUY	$1.07 - $1.55 $29,211 - $42,315	27,300 Added 14.41%	216,700 $282,000
Q1 2022 May 13, 2022	BUY	$1.21 - $2.24 $229,174 - $424,256	189,400 New	189,400 $277,000
Q2 2021 Aug 13, 2021	SELL	$31.5 - $42.5 $1.24 Million - $1.68 Million	-39,434 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$25.01 - $40.24 $560,224 - $901,376	22,400 Added 131.5%	39,434 $1.35 Million
Q4 2020 Feb 10, 2021	BUY	$28.66 - $46.79 $134,702 - $219,913	4,700 Added 38.11%	17,034 $620,000
Q3 2020 Nov 13, 2020	BUY	$14.71 - $50.69 $181,433 - $625,210	12,334 New	12,334 $598,000

Others Institutions Holding FBRX

# of Institutions

Shares Held

19M

Call Options Held

Put Options Held

View Full List

About Forte Biosciences, Inc.

Ticker FBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,340,300
Market Cap $12M
Description
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.

More about FBRX

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account